Comparative effectiveness research in obstructive sleep apnea: Bridging gaps between efficacy studies and clinical practice

Journal of Comparative Effectiveness Research

Volumn 1, Issue 1, 2012, Pages 83-105

  Weinstock, Tanya G ^a   Redline, Susan ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

cardiovascular disease; comparative effectiveness research; continuous positive airway pressure; heart failure; obstructive sleep apnea

Indexed keywords

PLACEBO;

APNEA HYPOPNEA INDEX; ARTIFICIAL VENTILATION; AUTOMATIC POSITIVE AIRWAY PRESSURE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; COGNITION; COMPARATIVE EFFECTIVENESS; CONSERVATIVE TREATMENT; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; NEUROLOGIC DISEASE; OBSERVATIONAL STUDY; OROPHARYNGEAL SURGERY; ORTHODONTIC DEVICE; PATIENT MONITORING; PILOT STUDY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCREENING; SLEEP APNEA SYNDROME; THROAT SURGERY; UVULOPALATOPHARYNGOPLASTY;

EID: 84866727215     PISSN: 20426305     EISSN: 20426313     Source Type: Journal    
DOI: 10.2217/cer.11.12     Document Type: Review

References (103)

1. Selker HP, Strom BL, Ford DE et al. White paper on CTSA consortium role in facilitating comparative effectiveness research: September 23, 2009 CTSA consortium strategic goal committee on comparative effectiveness research. Clin. Transl. Sci. 3, 29-37 (2010).
2. US Federal Coordinating Council for Comparative Effectiveness Research, United States President, United States. Congress, United States. Department of Health and Human Services. Report to the President and the Congress. US Department of Health and Human Services, Washington, DC, USA (2009).
3. Iglehart JK. Prioritizing comparative-effectiveness research - IOM recommendations. N. Engl. J. Med. 361, 325-328 (2009).
4. Ruehland WR, Rochford PD, O'Donoghue FJ, Pierce RJ, Singh P, Thornton AT. The new AASM criteria for scoring hypopneas: impact on the apnea hypopnea index. Sleep 32, 150-157 (2009).
5. Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA 291, 2013-2016 (2004).
6. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc. Am. Thorac. Soc. 5, 136-143 (2008).
7. Ferguson KA, Cartwright R, Rogers R, Schmidt-Nowara W. Oral appliances for snoring and obstructive sleep apnea: a review. Sleep 29, 244-262 (2006).
8. Xiong YP, Yi HL, Yin SK et al. Predictors of surgical outcomes of uvulopalatopharyngoplasty for obstructive sleep apnea hypopnea syndrome. Otolaryngol. Head Neck Surg. doi:10.1177/0194599811420811 (2011) (Epub ahead of print).
9. Punjabi NM, Caffo BS, Goodwin JL et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. 6, e1000132 (2009).
10. Redline S, Yenokyan G, Gottlieb DJ et al. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am. J. Respir. Crit. Care Med. 182, 269-277 (2010).
11. Briones B, Adams N, Strauss M et al. Relationship between sleepiness and general health status. Sleep 19, 583-588 (1996).
12. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am. J. Respir. Crit. Care Med. 163, 1256-1276 (2001).
13. Kapuniai LE, Andrew DJ, Crowell DH, Pearce JW. Identifying sleep apnea from self-reports. Sleep 11, 430-436 (1988).
14. Chung F, Yegneswaran B, Liao P et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology 108, 812-821 (2008).
15. Chung F, Yegneswaran B, Liao P et al. Validation of the Berlin questionnaire and American Society of Anesthesiologists checklist as screening tools for obstructive sleep apnea in surgical patients. Anesthesiology 108, 822-830 (2008).
16. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin questionnaire to identify patients at risk for the sleep apnea syndrome. Ann. Intern. Med. 131, 485-491 (1999).
17. Sharma SK, Vasudev C, Sinha S, Banga A, Pandey RM, Handa KK. Validation of the modified Berlin questionnaire to identify patients at risk for the obstructive sleep apnoea syndrome. Indian J. Med. Res. 124, 281-290 (2006).
18. Gurubhagavatula I, Maislin G, Pack AI. An algorithm to stratify sleep apnea risk in a sleep disorders clinic population. Am. J. Respir. Crit. Care Med. 164, 1904-1909 (2001).
19. EPC T-NEMC. Home diagnosis of obstructive sleep apnea-hypopnea syndrome. In: Health Technology Assessment Database. Agency for Healthcare Research and Quality, Rockville, MD, USA (2007).
20. Agency for Healthcare Research and Quality. Comparative Effectiveness of Diagnosis and Treatment of Obstructive Sleep Apnea in Adults. Agency for Healthcare Research and Quality, Rockville, MD, USA (2011).
21. Masa JF, Corral J, Pereira R et al. Effectiveness of home respiratory polygraphy for the diagnosis of sleep apnoea and hypopnoea syndrome. Thorax 66, 567-573 (2011).
22. Kuna ST, Gurubhagavatula I, Maislin G et al. Noninferiority of functional outcome in ambulatory management of obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 183, 1238-1244 (2011).
23. Naismith SL, Winter VR, Hickie IB, Cistulli PA. Effect of oral appliance therapy on neurobehavioral functioning in obstructive sleep apnea: a randomized controlled trial. J. Clin. Sleep Med. 1, 374-380 (2005).
24. Gotsopoulos H, Kelly JJ, Cistulli PA. Oral appliance therapy reduces blood pressure in obstructive sleep apnea: a randomized, controlled trial. Sleep 27, 934-941 (2004).
25. Gotsopoulos H, Chen C, Qian J, Cistulli PA. Oral appliance therapy improves symptoms in obstructive sleep apnea: a randomized, controlled trial. Am. J. Respir. Crit. Care Med. 166, 743-748 (2002).
26. Johnston CD, Gleadhill IC, Cinnamond MJ, Gabbey J, Burden DJ. Mandibular advancement appliances and obstructive sleep apnoea: a randomized clinical trial. Eur. J. Orthod. 24, 251-262 (2002).
27. Mehta A, Qian J, Petocz P, Darendeliler MA, Cistulli PA. A randomized, controlled study of a mandibular advancement splint for obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 163, 1457-1461 (2001).
28. Hans MG, Nelson S, Luks VG, Lorkovich P, Baek SJ. Comparison of two dental devices for treatment of obstructive sleep apnea syndrome (OSAS). Am. J. Orthod. Dentofacial. Orthop. 111, 562-570 (1997).
29. Campbell AJ, Reynolds G, Trengrove H, Neill AM. Mandibular advancement splint titration in obstructive sleep apnoea. Sleep Breath. 13, 157-162 (2009).
30. Vanderveken OM, Devolder A, Marklund M et al. Comparison of a custom-made and a thermoplastic oral appliance for the treatment of mild sleep apnea. Am. J. Respir. Crit. Care Med. 178, 197-202 (2008).
31. Walker-Engstrom ML, Ringqvist I, Vestling O, Wilhelmsson B, Tegelberg A. A prospective randomized study comparing two different degrees of mandibular advancement with a dental appliance in treatment of severe obstructive sleep apnea. Sleep Breath. 7, 119-130 (2003).
32. Deane SA, Cistulli PA, Ng AT, Zeng B, Petocz P, Darendeliler MA. Comparison of mandibular advancement splint and tongue stabilizing device in obstructive sleep apnea: a randomized controlled trial. Sleep 32, 648-653 (2009).
33. Bloch KE, Iseli A, Zhang JN et al. A randomized, controlled crossover trial of two oral appliances for sleep apnea treatment. Am. J. Respir. Crit. Care Med. 162, 246-251 (2000).
34. Kato J, Isono S, Tanaka A et al. Dose-dependent effects of mandibular advancement on pharyngeal mechanics and nocturnal oxygenation in patients with sleep-disordered breathing. Chest 117, 1065-1072 (2000).
35. Petri N, Svanholt P, Solow B, Wildschiodtz G, Winkel P. Mandibular advancement appliance for obstructive sleep apnoea: results of a randomised placebo controlled trial using parallel group design. J. Sleep Res. 17, 221-229 (2008).
36. Blanco J, Zamarron C, Abeleira Pazos MT, Lamela C, Suarez Quintanilla D. Prospective evaluation of an oral appliance in the treatment of obstructive sleep apnea syndrome. Sleep Breath. 9, 20-25 (2005).
37. Barnes M, McEvoy RD, Banks S et al. Efficacy of positive airway pressure and oral appliance in mild-to-moderate obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 170, 656-664 (2004).
38. Lam B, Sam K, Mok WY et al. Randomised study of three non-surgical treatments in mild-to-moderate obstructive sleep apnoea. Thorax 62, 354-359 (2007).
39. Clark GT, Blumenfeld I, Yoffe N, Peled E, Lavie P. A crossover study comparing the efficacy of continuous positive airway pressure with anterior mandibular positioning devices on patients with obstructive sleep apnea. Chest 109, 1477-1483 (1996).
40. Engleman HM, McDonald JP, Graham D et al. Randomized crossover trial of two treatments for sleep apnea/hypopnea syndrome: continuous positive airway pressure and mandibular repositioning splint. Am. J. Respir. Crit. Care Med. 166, 855-859 (2002).
41. Ferguson KA, Ono T, Lowe AA, Keenan SP, Fleetham JA. A randomized crossover study of an oral appliance vs nasal-continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnea. Chest 109, 1269-1275 (1996).
42. Gagnadoux F, Fleury B, Vielle B et al. Titrated mandibular advancement versus positive airway pressure for sleep apnoea. Eur. Respir. J. 34, 914-920 (2009).
43. Ferguson KA, Ono T, Lowe AA, Keenan SP, Fleetham JA. A randomized crossover study of an oral appliance vs nasal-continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnea. Chest 109, 1269-1275 (1996).
44. Gagnadoux F, Fleury B, Vielle B et al. Titrated mandibular advancement versus positive airway pressure for sleep apnoea. Eur. Respir. J. 34, 914-920 (2009).
45. Kohler M, Ayers L, Pepperell JC et al. Effects of continuous positive airway pressure on systemic inflammation in patients with moderate-to-severe obstructive sleep apnoea: a randomised controlled trial. Thorax 64, 67-73 (2009).
46. Comondore VR, Cheema R, Fox J et al. The impact of CPAP on cardiovascular biomarkers in minimally symptomatic patients with obstructive sleep apnea: a pilot feasibility randomized crossover trial. Lung 187, 17-22 (2009).
47. Damjanovic D, Fluck A, Bremer H, Muller-Quernheim J, Idzko M, Sorichter S. Compliance in sleep apnoea therapy: influence of home care support and pressure mode. Eur. Respir. J. 33, 804-811 (2009).
48. To KW, Chan WC, Choo KL, Lam WK, Wong KK, Hui DS. A randomized crossover study of auto-continuous positive airway pressure versus fixed-continuous positive airway pressure in patients with obstructive sleep apnoea. Respirology 13, 79-86 (2008).
49. Galetke W, Anduleit N, Richter K, Stieglitz S, Randerath WJ. Comparison of automatic and continuous positive airway pressure in a night-by-night analysis: a randomized, crossover study. Respiration 75, 163-169 (2008).
50. Meurice JC, Cornette A, Philip-Joet F et al. Evaluation of autoCPAP devices in home treatment of sleep apnea/hypopnea syndrome. Sleep Med. 8, 695-703 (2007).
51. Fietze I, Glos M, Moebus I, Witt C, Penzel T, Baumann G. Automatic pressure titration with APAP is as effective as manual titration with CPAP in patients with obstructive sleep apnea. Respiration 74, 279-286 (2007).
52. Patruno V, Aiolfi S, Costantino G et al. Fixed and autoadjusting continuous positive airway pressure treatments are not similar in reducing cardiovascular risk factors in patients with obstructive sleep apnea. Chest 131, 1393-1399 (2007).
53. Kushida CA, Berry RB, Blau A et al. Positive airway pressure initiation: a randomized controlled trial to assess the impact of therapy mode and titration process on efficacy, adherence, and outcomes. Sleep 34, 1083-1092 (2011).
54. Kohler M, Ayers L, Pepperell JC et al. Effects of continuous positive airway pressure on systemic inflammation in patients with moderate-to-severe obstructive sleep apnoea: a randomised controlled trial. Thorax 64, 67-73 (2009).
55. Comondore VR, Cheema R, Fox J et al. The impact of CPAP on cardiovascular biomarkers in minimally symptomatic patients with obstructive sleep apnea: a pilot feasibility randomized crossover trial. Lung 187, 17-22 (2009).
56. Damjanovic D, Fluck A, Bremer H, Muller-Quernheim J, Idzko M, Sorichter S. Compliance in sleep apnoea therapy: influence of home care support and pressure mode. Eur. Respir. J. 33, 804-811 (2009).
57. To KW, Chan WC, Choo KL, Lam WK, Wong KK, Hui DS. A randomized crossover study of auto-continuous positive airway pressure versus fixed-continuous positive airway pressure in patients with obstructive sleep apnoea. Respirology 13, 79-86 (2008).
58. Galetke W, Anduleit N, Richter K, Stieglitz S, Randerath WJ. Comparison of automatic and continuous positive airway pressure in a night-by-night analysis: a randomized, crossover study. Respiration 75, 163-169 (2008).
59. Meurice JC, Cornette A, Philip-Joet F et al. Evaluation of autoCPAP devices in home treatment of sleep apnea/hypopnea syndrome. Sleep Med. 8, 695-703 (2007).
60. Fietze I, Glos M, Moebus I, Witt C, Penzel T, Baumann G. Automatic pressure titration with APAP is as effective as manual titration with CPAP in patients with obstructive sleep apnea. Respiration 74, 279-286 (2007).
61. Patruno V, Aiolfi S, Costantino G et al. Fixed and autoadjusting continuous positive airway pressure treatments are not similar in reducing cardiovascular risk factors in patients with obstructive sleep apnea. Chest 131, 1393-1399 (2007).
62. Kushida CA, Berry RB, Blau A et al. Positive airway pressure initiation: a randomized controlled trial to assess the impact of therapy mode and titration process on efficacy, adherence, and outcomes. Sleep 34, 1083-1092 (2011).
63. Van Cautre E, Blackman JD, Roland D, Spire JP, Refetoff S, Polonsky KS. Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep. J. Clin. Invest. 88, 934-942 (1991).
64. Foster GD, Sanders MH, Millman R et al. Obstructive sleep apnea among obese patients with Type 2 diabetes. Diabetes Care 32, 1017-1019 (2009).
65. Resnick HE, Redline S, Shahar E et al. Diabetes and sleep disturbances: findings from the Sleep Heart Health study. Diabetes Care 26, 702-709 (2003).
66. McArdle N, Hillman D, Beilin L, Watts G. Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am. J. Respir. Crit. Care Med. 175, 190-195 (2007).
67. Pillai A, Warren G, Gunathilake W, Idris I. Effects of sleep apnea severity on glycemic control in patients with Type 2 diabetes prior to continuous positive airway presssure treatment. Diabetes Technol. Ther. 13, 945-949 (2011).
68. Aronsohn RS, Whitmore H, Van Cauter E, Tasali E. Impact of untreated obstructive sleep apnea on glucose control in Type 2 diabetes. Am. J. Respir. Crit. Care Med. 181, 507-513 (2010).
69. Otake K, Sasanabe R, Hasegawa R et al. Glucose intolerance in Japanese patients with obstructive sleep apnea. Intern. Med. 48, 1863-1868 (2009).
70. Tamura A, Kawano Y, Watanabe T, Kadota J. Relationship between the severity of obstructive sleep apnea and impaired glucose metabolism in patients with obstructive sleep apnea. Respir. Med. 102, 1412-1416 (2008).
71. Papanas N, Steiropoulos P, Nena E et al. HbA1c is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men. Vasc. Health Risk Manag. 5, 751-756 (2009).
72. Kosseifi S, Bailey B, Price R, Roy TM, Byrd RP Jr, Peiris AN. The association between obstructive sleep apnea syndrome and microvascular complications in well-controlled diabetic patients. Mil. Med. 175, 913-916 (2010).
73. Stamatakis K, Sanders MH, Caffo B et al. Fasting glycemia in sleep disordered breathing: lowering the threshold on oxyhemoglobin desaturation. Sleep 31, 1018-1024 (2008).
74. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE. Sleep disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am. J. Epidemiol. 160, 521-530 (2004).
75. Celen YT, Hedner J, Carlson J, Peker Y. Impact of gender on incident diabetes mellitus in obstructive sleep apnea: a 16 year follow-up. J. Clin. Sleep Med. 6, 244-250 (2010).
76. Botros N, Concato J, Mohsenin V, Selim B, Doctor K, Yaggi HK. Obstructive sleep apnea as a risk factor for Type 2 diabetes. Am. J. Med. 122, 1122-1127 (2009).
77. Muraki I, Tanigawa T, Yamagishi K et al. Nocturnal intermittent hypoxia and the development of Type 2 diabetes: the Circulatory Risk in Communities Study (CIRCS). Diabetologia 53, 481-488 (2010).
78. Ronksley PE, Hemmelgarn BR, Heitman SJ et al. Obstructive sleep apnoea is associated with diabetes in sleepy subjects. Thorax 64, 834-839 (2009).
79. Duran-Cantolla J, Aizpuru F, Montserrat JM et al. Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial. BMJ 341, c5991 (2010).
80. Bradley TD, Logan AG, Kimoff RJ et al. Continuous positive airway pressure for central sleep apnea and heart failure. N. Engl. J. Med. 353, 2025-2033 (2005).
81. Arzt M, Floras JS, Logan AG et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 115, 3173-3180 (2007).
82. Barbé F, Duran-Cantolla J, Capote F et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am. J. Respir. Crit. Care Med. 181, 718-726 (2010).
83. Craig SE, Kohler M, Nicoll D et al. Assessing the impact of interventions in sleep-disordered breathing: S13. The primary results of the MOSAIC trial: does CPAP for minimally symptomatic OSA reduce daytime sleepiness or calculated vascular risk? Thorax 65(Suppl. 4), A9 (2010).
84. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 343, 572-575 (1994).
85. Engleman HM, Kingshott RN, Wraith PK, Mackay TW, Deary IJ, Douglas NJ. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep Apnea/Hypopnea syndrome. Am. J. Respir. Crit. Care Med. 159, 461-467 (1999).
86. Parra O, Sanchez-Armengol A, Bonnin M et al. Early treatment of obstructive apnoea and stroke outcome: a randomised controlled trial. Eur. Respir. J. 37, 1128-1136 (2011).
87. Brooks B, Cistulli PA, Borkman M et al. Obstructive sleep apnea in obese non-insulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J. Clin. Endocrinol. Metab. 79, 1681-1685 (1994).
88. Chin K, Ohi M, Kita H et al. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am. J. Respir. Crit. Care Med. 153, 1972-1976 (1996).
89. Cuhadaroglu C, Utkusavas A, Ozturk L, Salman S, Ece T. Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea. Lung 187, 75-81 (2009).
90. Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R. Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest 134, 686-692 (2008).
91. Phillips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME, Somers VK. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J. Hypertens. 17, 61-66 (1999).
92. Kimura H, Niijima M, Abe Y et al. Compensatory excretion of prostacyclin and thromboxane metabolites in obstructive sleep apnea syndrome. Intern. Med. 37, 127-133 (1998).
93. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am. J. Respir. Crit. Care Med. 165, 934-939 (2002).
94. Ip MS, Lam B, Chan LY et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am. J. Respir. Crit. Care Med. 162, 2166-2171 (2000).
95. Dawson A, Abel SL, Loving RT et al. CPAP therapy of obstructive sleep apnea in Type 2 diabetics improves glycemic control during sleep. J. Clin. Sleep Med. 4, 538-542 (2008).
96. Babu AR, Herdegen J, Fogelfeld L, Shott S, Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch. Intern. Med. 165, 447-452 (2005).
97. Harsch IA, Schahin SP, Radespiel-Troger M et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am. J. Respir. Crit. Care Med. 169, 156-162 (2004).
98. Lam JC, Lam B, Yao TJ et al. A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea. Eur. Respir. J. 35, 138-145 (2010).
99. Lieu TA, Au D, Krishnan JA et al. Comparative effectiveness research in lung diseases and sleep disorders: recommendations from the NHLBI workshop. Am. J. Respir. Crit. Care Med. doi:10.1164/rccm.201104-0634WS (2011) (Epub ahead of print).
100. Aloia MS, Arnedt JT, Riggs RL, Hecht J, Borrelli B. Clinical management of poor adherence to CPAP: motivational enhancement. Behav. Sleep Med. 2, 205-222 (2004).
101. Buchwald H, Avidor Y, Braunwald E et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 292, 1724-1737 (2004).
102. Dixon JB, Schachter LM, O'Brien PE. Sleep disturbance and obesity: changes following surgically induced weight loss. Arch. Intern. Med. 161, 102-106 (2001).
103. Flum DR, Belle SH, King WC et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N. Engl. J. Med. 36 1, 445-454 (2009).